HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mouse model for the DNA repair/basal transcription disorder trichothiodystrophy reveals cancer predisposition.

Abstract
Patients with the nucleotide excision repair (NER) disorder xeroderma pigmentosum (XP) are highly predisposed to develop sunlight-induced skin cancer, in remarkable contrast to photosensitive NER-deficient trichothiodystrophy (TTD) patients carrying mutations in the same XPD gene. XPD encodes a helicase subunit of the dually functional DNA repair/basal transcription complex TFIIH. The pleiotropic disease phenotype is hypothesized to be, in part, derived from a repair defect causing UV sensitivity and, in part, from a subtle, viable basal transcription deficiency accounting for the cutaneous, developmental, and the typical brittle hair features of TTD. To understand the relationship between deficient NER and tumor susceptibility, we used a mouse model for TTD that mimics an XPD point mutation of a TTD patient in the mouse germline. Like the fibroblasts from the patient, mouse cells exhibit a partial NER defect, evident from the reduced UV-induced DNA repair synthesis (residual repair capacity approximately 25%), limited recovery of RNA synthesis after UV exposure, and a relatively mild hypersensitivity to cell killing by UV or 7,12-dimethylbenz[a]anthracene. In accordance with the cellular studies, TTD mice exhibit a modestly increased sensitivity to UV-induced inflammation and hyperplasia of the skin. In striking contrast to the human syndrome, TTD mice manifest a dear susceptibility to UV- and 7,12-dimethylbenz[a]anthracene-induced skin carcinogenesis, albeit not as pronounced as the totally NER-deficient XPA mice. These findings open up the possibility that TTD is associated with a so far unnoticed cancer predisposition and support the notion that a NER deficiency enhances cancer susceptibility. These findings have important implications for the etiology of the human disorder and for the impact of NER on carcinogenesis.
AuthorsJ de Boer, H van Steeg, R J Berg, J Garssen, J de Wit, C T van Oostrum, R B Beems, G T van der Horst, C F van Kreijl, F R de Gruijl, D Bootsma, J H Hoeijmakers, G Weeda
JournalCancer research (Cancer Res) Vol. 59 Issue 14 Pg. 3489-94 (Jul 15 1999) ISSN: 0008-5472 [Print] United States
PMID10416615 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • DNA-Binding Proteins
  • Proteins
  • Transcription Factors
  • Transcription Factors, TFII
  • Transcription Factor TFIIH
  • 9,10-Dimethyl-1,2-benzanthracene
  • DNA Helicases
  • Xeroderma Pigmentosum Group D Protein
  • ERCC2 protein, human
  • Ercc2 protein, mouse
Topics
  • 9,10-Dimethyl-1,2-benzanthracene (toxicity)
  • Alleles
  • Animals
  • Cockayne Syndrome (genetics)
  • DNA Helicases
  • DNA Repair (genetics)
  • DNA-Binding Proteins
  • Disease Models, Animal
  • Fibroblasts (pathology, radiation effects)
  • Gene Targeting
  • Genetic Predisposition to Disease
  • Growth Disorders (genetics, pathology)
  • Hair Diseases (genetics, pathology)
  • Humans
  • Hyperplasia
  • Ichthyosis (genetics, pathology)
  • Mice
  • Mice, Inbred C57BL
  • Neoplastic Syndromes, Hereditary (genetics)
  • Point Mutation
  • Proteins (genetics, physiology)
  • Radiation Tolerance (genetics)
  • Skin (pathology, radiation effects)
  • Skin Neoplasms (chemically induced, genetics)
  • Transcription Factor TFIIH
  • Transcription Factors (deficiency, genetics, physiology)
  • Transcription Factors, TFII
  • Transcription, Genetic (genetics)
  • Ultraviolet Rays
  • Xeroderma Pigmentosum (genetics)
  • Xeroderma Pigmentosum Group D Protein

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: